Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques. (Q44235177)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2004

Language	Label	Description	Also known as
English	Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.	scientific article published in January 2004

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Simian immunodeficiency virus

0 references

Antonia Radaelli

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Janos Nacsa

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Yvette Edghill-Smith

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

David Venzon

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Wen-Po Tsai

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Carlo De Giuli Morghen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Dennis Panicali

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Jim Tartaglia

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Genoveffa Franchini

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

5-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

597-606

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

HIV and AIDS. Gap between biology and reality in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Crystalluria and urinary tract abnormalities associated with indinavir

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Studies of body composition and fat distribution in HIV-infected and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Visceral abdominal-fat accumulation associated with use of indinavir

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Changes in Frequency of HIV‐1–Specific Cytotoxic T Cell Precursors and Circulating Effectors after Combination Antiretroviral Therapy in Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Therapeutic dendritic-cell vaccine for simian AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Equivalent Immunogenicity of the Highly Attenuated Poxvirus-Based ALVAC-SIV and NYVAC-SIV Vaccine Candidates in SIVmac251-Infected Macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Formation of Lentivirus Particles by Mammalian Cells Infected with Recombinant Fowlpox Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.028

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.08.028

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14741150%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44235177&oldid=2153319411"